| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 68 | 2025 | 745 | 6.230 |
Why?
|
| Genetic Vectors | 39 | 2019 | 913 | 3.560 |
Why?
|
| Genetic Therapy | 20 | 2019 | 832 | 1.810 |
Why?
|
| Viral Proteins | 22 | 2009 | 271 | 1.650 |
Why?
|
| Baculoviridae | 8 | 2013 | 24 | 1.210 |
Why?
|
| DNA-Binding Proteins | 20 | 2004 | 1223 | 1.160 |
Why?
|
| Transduction, Genetic | 20 | 2016 | 242 | 1.120 |
Why?
|
| Recombination, Genetic | 18 | 2008 | 255 | 1.030 |
Why?
|
| DNA, Viral | 17 | 2011 | 231 | 0.960 |
Why?
|
| Gene Transfer Techniques | 16 | 2016 | 324 | 0.910 |
Why?
|
| Bioreactors | 5 | 2011 | 36 | 0.800 |
Why?
|
| Insecta | 6 | 2011 | 36 | 0.640 |
Why?
|
| Virus Replication | 6 | 2013 | 323 | 0.630 |
Why?
|
| Invertebrates | 2 | 2017 | 20 | 0.600 |
Why?
|
| Animals | 53 | 2022 | 21341 | 0.570 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2005 | 94 | 0.570 |
Why?
|
| Molecular Sequence Data | 24 | 2012 | 1985 | 0.560 |
Why?
|
| Dystrophin | 3 | 2014 | 30 | 0.560 |
Why?
|
| Muscular Dystrophy, Duchenne | 3 | 2014 | 44 | 0.530 |
Why?
|
| Cell Line | 18 | 2017 | 2036 | 0.520 |
Why?
|
| Cloning, Molecular | 11 | 2008 | 384 | 0.510 |
Why?
|
| Genome, Viral | 6 | 2013 | 144 | 0.500 |
Why?
|
| RNA, Small Nuclear | 2 | 2014 | 25 | 0.470 |
Why?
|
| Transfection | 3 | 2013 | 700 | 0.460 |
Why?
|
| Capsid Proteins | 4 | 2025 | 105 | 0.460 |
Why?
|
| Blotting, Western | 8 | 2012 | 610 | 0.440 |
Why?
|
| DNA, Recombinant | 2 | 2013 | 47 | 0.420 |
Why?
|
| Base Sequence | 20 | 2012 | 1329 | 0.410 |
Why?
|
| Virus Integration | 5 | 1996 | 33 | 0.380 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2005 | 49 | 0.350 |
Why?
|
| DNA | 5 | 2013 | 852 | 0.340 |
Why?
|
| Gene Expression | 9 | 2016 | 856 | 0.330 |
Why?
|
| Plasmids | 6 | 2005 | 293 | 0.320 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2008 | 23 | 0.320 |
Why?
|
| Chromatography, Gel | 2 | 2008 | 63 | 0.320 |
Why?
|
| DNA Replication | 8 | 2011 | 247 | 0.310 |
Why?
|
| Adenoviridae | 4 | 2007 | 130 | 0.300 |
Why?
|
| Capsid | 4 | 2025 | 102 | 0.300 |
Why?
|
| Genetic Techniques | 1 | 2009 | 38 | 0.300 |
Why?
|
| Bocavirus | 1 | 2009 | 2 | 0.300 |
Why?
|
| Parvoviridae Infections | 1 | 2009 | 23 | 0.290 |
Why?
|
| Humans | 51 | 2025 | 64901 | 0.290 |
Why?
|
| Virus Cultivation | 2 | 2007 | 19 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 19 | 6 | 1995 | 17 | 0.270 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 794 | 0.260 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 326 | 0.260 |
Why?
|
| Biotechnology | 1 | 2007 | 37 | 0.260 |
Why?
|
| Spodoptera | 4 | 2013 | 27 | 0.260 |
Why?
|
| Molecular Biology | 1 | 2008 | 65 | 0.260 |
Why?
|
| Amino Acid Sequence | 9 | 2009 | 1594 | 0.250 |
Why?
|
| Transgenes | 3 | 2016 | 202 | 0.250 |
Why?
|
| Recombinant Proteins | 9 | 2008 | 711 | 0.240 |
Why?
|
| Bisbenzimidazole | 1 | 2005 | 3 | 0.230 |
Why?
|
| Genes, Viral | 2 | 1998 | 57 | 0.220 |
Why?
|
| Benzimidazoles | 1 | 2005 | 56 | 0.220 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 158 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 2238 | 0.210 |
Why?
|
| HeLa Cells | 9 | 1999 | 543 | 0.200 |
Why?
|
| Replication Origin | 2 | 2002 | 36 | 0.200 |
Why?
|
| Sf9 Cells | 2 | 2013 | 8 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 9 | 2011 | 374 | 0.190 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 897 | 0.190 |
Why?
|
| Parvovirus | 1 | 2022 | 25 | 0.190 |
Why?
|
| Glucose | 2 | 2008 | 476 | 0.190 |
Why?
|
| Transposases | 1 | 2002 | 18 | 0.190 |
Why?
|
| Vertebrates | 1 | 2022 | 44 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 9 | 2002 | 243 | 0.180 |
Why?
|
| Densovirus | 1 | 2002 | 1 | 0.180 |
Why?
|
| COS Cells | 6 | 2003 | 180 | 0.180 |
Why?
|
| Mice | 16 | 2016 | 11114 | 0.180 |
Why?
|
| DNA Helicases | 3 | 1998 | 198 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 980 | 0.170 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2002 | 94 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 1994 | 43 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 1994 | 38 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 348 | 0.150 |
Why?
|
| Quality Control | 1 | 2019 | 78 | 0.150 |
Why?
|
| Genetic Engineering | 2 | 2013 | 113 | 0.150 |
Why?
|
| Terminal Repeat Sequences | 1 | 1999 | 13 | 0.150 |
Why?
|
| Caspases | 1 | 2000 | 176 | 0.150 |
Why?
|
| Commerce | 1 | 2019 | 58 | 0.150 |
Why?
|
| Dogs | 4 | 2014 | 316 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 2000 | 107 | 0.150 |
Why?
|
| Antigens, CD | 3 | 1998 | 344 | 0.140 |
Why?
|
| Trans-Activators | 2 | 1998 | 321 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2009 | 185 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2000 | 286 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 6 | 2003 | 687 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 312 | 0.140 |
Why?
|
| Central Nervous System | 2 | 2016 | 200 | 0.140 |
Why?
|
| Retina | 3 | 2003 | 133 | 0.140 |
Why?
|
| Protein Kinases | 1 | 1998 | 152 | 0.130 |
Why?
|
| Exons | 3 | 2014 | 205 | 0.130 |
Why?
|
| Escherichia coli Proteins | 3 | 1994 | 275 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 6 | 1999 | 502 | 0.130 |
Why?
|
| Rats | 9 | 2007 | 1995 | 0.130 |
Why?
|
| Rabbits | 3 | 2009 | 338 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 1998 | 663 | 0.130 |
Why?
|
| Carrier Proteins | 5 | 2012 | 719 | 0.130 |
Why?
|
| Marsupialia | 1 | 2016 | 5 | 0.120 |
Why?
|
| Binding Sites | 7 | 2004 | 920 | 0.120 |
Why?
|
| Fossils | 1 | 2016 | 7 | 0.120 |
Why?
|
| Neoplasms | 1 | 2007 | 1362 | 0.120 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 41 | 0.120 |
Why?
|
| Viral Tropism | 1 | 2016 | 53 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 118 | 0.110 |
Why?
|
| Muscles | 1 | 2016 | 179 | 0.110 |
Why?
|
| Apoptosis | 1 | 2000 | 1095 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 543 | 0.110 |
Why?
|
| Lymphocytes | 1 | 1995 | 204 | 0.110 |
Why?
|
| Forelimb | 1 | 2014 | 11 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2008 | 206 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 513 | 0.100 |
Why?
|
| Spectrum Analysis | 2 | 2007 | 50 | 0.100 |
Why?
|
| Endonucleases | 3 | 2011 | 84 | 0.100 |
Why?
|
| Substrate Specificity | 4 | 2004 | 337 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 2284 | 0.100 |
Why?
|
| Insect Vectors | 1 | 2013 | 15 | 0.100 |
Why?
|
| Myocardium | 2 | 2012 | 301 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2002 | 907 | 0.090 |
Why?
|
| Brain | 4 | 2007 | 1598 | 0.090 |
Why?
|
| Cricetinae | 3 | 2000 | 369 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 430 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 240 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1997 | 85 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 129 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2002 | 266 | 0.090 |
Why?
|
| Virology | 1 | 2011 | 13 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 364 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 129 | 0.080 |
Why?
|
| RNA Interference | 2 | 2005 | 643 | 0.080 |
Why?
|
| Insulin | 2 | 2008 | 696 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2012 | 189 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2011 | 138 | 0.080 |
Why?
|
| Luminescent Proteins | 4 | 2003 | 130 | 0.080 |
Why?
|
| Antigens, Viral | 2 | 2009 | 131 | 0.080 |
Why?
|
| Salivary Glands | 2 | 2002 | 45 | 0.080 |
Why?
|
| Haplorhini | 2 | 2002 | 14 | 0.080 |
Why?
|
| Virion | 2 | 2003 | 122 | 0.080 |
Why?
|
| RNA, Ribosomal | 3 | 1986 | 60 | 0.080 |
Why?
|
| Male | 9 | 2013 | 30898 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 195 | 0.080 |
Why?
|
| Genome, Human | 1 | 2011 | 237 | 0.080 |
Why?
|
| Protein Binding | 5 | 2012 | 1642 | 0.080 |
Why?
|
| Virosomes | 1 | 2009 | 5 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 51 | 0.070 |
Why?
|
| Crystallization | 2 | 2025 | 98 | 0.070 |
Why?
|
| Serum | 1 | 2009 | 27 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2009 | 51 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 3755 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2009 | 193 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 139 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 522 | 0.070 |
Why?
|
| Simplexvirus | 1 | 2008 | 26 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 251 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2004 | 2190 | 0.070 |
Why?
|
| Industry | 1 | 2008 | 59 | 0.070 |
Why?
|
| Ultracentrifugation | 1 | 2008 | 28 | 0.070 |
Why?
|
| Biomass | 1 | 2008 | 20 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 1560 | 0.070 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1987 | 11 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 450 | 0.070 |
Why?
|
| Blotting, Southern | 2 | 2002 | 56 | 0.070 |
Why?
|
| Oxides | 1 | 2007 | 36 | 0.070 |
Why?
|
| Catalysis | 2 | 2000 | 164 | 0.070 |
Why?
|
| DNA Probes | 3 | 1994 | 33 | 0.060 |
Why?
|
| Serotyping | 3 | 2006 | 52 | 0.060 |
Why?
|
| Kinetochores | 1 | 2007 | 26 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 1984 | 86 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 77 | 0.060 |
Why?
|
| Glioblastoma | 2 | 2006 | 160 | 0.060 |
Why?
|
| Iron | 1 | 2007 | 150 | 0.060 |
Why?
|
| Kinetics | 3 | 2002 | 759 | 0.060 |
Why?
|
| B7-1 Antigen | 2 | 1997 | 74 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2007 | 287 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 302 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1690 | 0.060 |
Why?
|
| TATA Box | 2 | 1999 | 11 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 172 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1997 | 111 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2007 | 311 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 204 | 0.060 |
Why?
|
| Glioma | 1 | 2006 | 99 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 403 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2007 | 180 | 0.060 |
Why?
|
| Fetal Development | 1 | 2005 | 15 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1572 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2007 | 666 | 0.060 |
Why?
|
| Contrast Media | 1 | 2007 | 429 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2005 | 198 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2005 | 1634 | 0.050 |
Why?
|
| Epithelial Cells | 4 | 2002 | 418 | 0.050 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2004 | 12 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2005 | 127 | 0.050 |
Why?
|
| Restriction Mapping | 2 | 1997 | 49 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 10 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 68 | 0.050 |
Why?
|
| Luciferases | 2 | 2002 | 105 | 0.050 |
Why?
|
| Liver | 1 | 2008 | 868 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2005 | 159 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2012 | 3472 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2005 | 396 | 0.050 |
Why?
|
| Acclimatization | 1 | 2022 | 11 | 0.050 |
Why?
|
| Cesium | 1 | 2002 | 6 | 0.050 |
Why?
|
| Ecology | 1 | 2022 | 14 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2002 | 35 | 0.050 |
Why?
|
| Agriculture | 1 | 2022 | 31 | 0.050 |
Why?
|
| Chlorides | 1 | 2002 | 32 | 0.050 |
Why?
|
| B7-2 Antigen | 3 | 1998 | 32 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2002 | 217 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2002 | 84 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 318 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2016 | 259 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 223 | 0.040 |
Why?
|
| Heparin | 1 | 2002 | 118 | 0.040 |
Why?
|
| Kidney | 2 | 2002 | 451 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 295 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2002 | 164 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2000 | 17 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2016 | 1159 | 0.040 |
Why?
|
| Female | 4 | 2012 | 33861 | 0.040 |
Why?
|
| G1 Phase | 1 | 2000 | 58 | 0.040 |
Why?
|
| Maltose-Binding Proteins | 3 | 1994 | 4 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 108 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2000 | 53 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 392 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 853 | 0.040 |
Why?
|
| Phosphorylation | 2 | 1999 | 962 | 0.040 |
Why?
|
| Aquaporins | 1 | 1998 | 6 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 426 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 46 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 4783 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2000 | 256 | 0.040 |
Why?
|
| DNA Damage | 1 | 2000 | 292 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2006 | 677 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2000 | 581 | 0.030 |
Why?
|
| Adolescent | 1 | 2009 | 6283 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 1998 | 51 | 0.030 |
Why?
|
| Hemagglutination Tests | 1 | 1997 | 3 | 0.030 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1997 | 4 | 0.030 |
Why?
|
| beta-Galactosidase | 3 | 2005 | 84 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1997 | 111 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 162 | 0.030 |
Why?
|
| Mutation | 2 | 2011 | 2659 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1995 | 34 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 146 | 0.030 |
Why?
|
| Genes | 3 | 1986 | 90 | 0.030 |
Why?
|
| Rats, Nude | 2 | 2006 | 25 | 0.030 |
Why?
|
| Spheroids, Cellular | 2 | 2006 | 28 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 30 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 2007 | 48 | 0.030 |
Why?
|
| United States | 1 | 2009 | 8062 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 173 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 200 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 300 | 0.030 |
Why?
|
| Genes, ras | 1 | 1994 | 28 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 175 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 366 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 1994 | 32 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 348 | 0.030 |
Why?
|
| Photoreceptor Cells | 2 | 2003 | 18 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 790 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 14882 | 0.020 |
Why?
|
| Macaca | 1 | 2012 | 30 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 1997 | 366 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 37 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 33 | 0.020 |
Why?
|
| Rats, Wistar | 2 | 2002 | 182 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1989 | 100 | 0.020 |
Why?
|
| Adult | 1 | 2009 | 17278 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 18169 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 340 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2011 | 105 | 0.020 |
Why?
|
| Fibrosis | 1 | 2011 | 172 | 0.020 |
Why?
|
| Submandibular Gland | 2 | 2002 | 5 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2003 | 246 | 0.020 |
Why?
|
| KB Cells | 1 | 1990 | 2 | 0.020 |
Why?
|
| Lysogeny | 1 | 1990 | 8 | 0.020 |
Why?
|
| Clone Cells | 1 | 1990 | 112 | 0.020 |
Why?
|
| Proviruses | 1 | 1990 | 27 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 673 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 1990 | 52 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1994 | 708 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1994 | 744 | 0.020 |
Why?
|
| Bucladesine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 8 | 0.020 |
Why?
|
| Imines | 1 | 2008 | 4 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2008 | 6 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 25 | 0.020 |
Why?
|
| Streptozocin | 1 | 2008 | 23 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 510 | 0.020 |
Why?
|
| Methanol | 1 | 1987 | 10 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2609 | 0.020 |
Why?
|
| Freezing | 1 | 1987 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2002 | 356 | 0.020 |
Why?
|
| Cytidine Monophosphate | 1 | 1987 | 9 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1987 | 67 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2007 | 17 | 0.020 |
Why?
|
| Convection | 1 | 2007 | 10 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2007 | 21 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 45 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2007 | 29 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1987 | 196 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2007 | 106 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 26 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 168 | 0.020 |
Why?
|
| Nucleic Acid Precursors | 1 | 1986 | 2 | 0.020 |
Why?
|
| Cycloleucine | 1 | 1986 | 7 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 46 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 622 | 0.010 |
Why?
|
| Particle Size | 1 | 2007 | 428 | 0.010 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2006 | 48 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2005 | 47 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 186 | 0.010 |
Why?
|
| Aedes | 1 | 1984 | 13 | 0.010 |
Why?
|
| Amino Acids | 1 | 1986 | 148 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Ataxins | 1 | 2004 | 5 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2004 | 5 | 0.010 |
Why?
|
| Ethanol | 1 | 1987 | 329 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 152 | 0.010 |
Why?
|
| Huntingtin Protein | 1 | 2005 | 147 | 0.010 |
Why?
|
| Glutamine | 1 | 2004 | 50 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 18 | 0.010 |
Why?
|
| Electroretinography | 1 | 2003 | 26 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 114 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2003 | 89 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 136 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 699 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 119 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 94 | 0.010 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2002 | 12 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 260 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2002 | 25 | 0.010 |
Why?
|
| Calorimetry | 1 | 2002 | 39 | 0.010 |
Why?
|
| Injections | 1 | 2002 | 83 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2002 | 126 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 347 | 0.010 |
Why?
|
| Tail | 1 | 2002 | 7 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 430 | 0.010 |
Why?
|
| Bacillus | 1 | 2002 | 14 | 0.010 |
Why?
|
| Mitochondria | 1 | 1986 | 402 | 0.010 |
Why?
|
| Static Electricity | 1 | 2002 | 170 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 419 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1290 | 0.010 |
Why?
|
| Protein Folding | 1 | 2002 | 269 | 0.010 |
Why?
|
| Methylation | 2 | 1994 | 129 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 870 | 0.010 |
Why?
|
| Bronchi | 1 | 2000 | 84 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 1999 | 1 | 0.010 |
Why?
|
| Aquaporin 1 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Microinjections | 1 | 1999 | 68 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1998 | 6 | 0.010 |
Why?
|
| X Chromosome | 1 | 1999 | 51 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 40 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1999 | 144 | 0.010 |
Why?
|
| HT29 Cells | 1 | 1998 | 28 | 0.010 |
Why?
|
| X-Rays | 1 | 1998 | 46 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 1999 | 201 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1997 | 3 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 46 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 367 | 0.010 |
Why?
|
| Water | 1 | 1998 | 313 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1997 | 166 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 2154 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1998 | 165 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1997 | 173 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1997 | 370 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1997 | 265 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 752 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 25 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 332 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1994 | 97 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 493 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 244 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1988 | 17 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1994 | 1551 | 0.000 |
Why?
|
| RNA Precursors | 1 | 1986 | 78 | 0.000 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1984 | 5 | 0.000 |
Why?
|